Guangdong VTR Bio-Tech Co., Ltd. completed the acquisition of 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH.
January 04, 2024
Share
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) agreed to acquire 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH on August 25, 2023. On August 25, 2023. Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) signed share transfer agreement to acquire 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH for CNY 80 million on October 23, 2023. On August 25, 2023, This has been approved by Guangdong VTR Bio-Tech Co., Ltd. 7th directorate during its 31st meeting. The transaction is approved by board of directors of Guangdong VTR Bio-Tech Co., Ltd in 32nd meeting of the seventh board of directors. This does not require approval by the company?s shareholders? meeting. As of December 13, 2023, parties signed supplementary agreement, The supplementary agreement was only adjustments in payment terms and order of processes, and did not require approval by the board of directors.
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) completed the acquisition of 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH on January 5, 2024.
Guangdong VTR Bio-Tech Co Ltd is a China-based company mainly engaged in biotechnology services. The Company is mainly engaged in the research and development, production, sales and service of bioenzyme preparations, biosynthetic products and nutrition and health products, and provides customers with overall biotechnology solutions. The bioenzyme preparations are used in many fields such as feed, food, energy, pharmaceuticals, textiles, papermaking, environmental protection, brewing, starch sugar, detergents and health products. The biosynthetic products include medicines, food, feed, cosmetics, medical devices, and others. The nutrition and health products are mainly animal nutrition and health products, including feed additives, plant extracts, and others.